source
- STAT+: Hair-raising trial results, and Servier’s M&A wishlistWhy are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout LOUD," STAT's weekly biotech podcast.STAT · 3mo ago↗ source
- FDA's oncology advisors vote against 'new paradigm' in AstraZeneca trialIn its first meeting in about nine months, the FDA’s advisory committee of oncology experts voted 6-3 Thursday that a late-stage trial for AstraZeneca’s oral SERD camizestrant didn't show a “clinic…Endpoints · 3mo ago↗ source
- Krazati fails confirmatory trial in colorectal cancer, putting approval at riskBristol Myers Squibb’s cancer drug Krazati has failed its confirmatory study in second-line colorectal cancer, a company spokesperson confirmed to Endpoints News. Krazati had received accelerated a…